Product Details for ANDA 201722
NITROFURANTOIN (NITROFURANTOIN, MACROCRYSTALLINE)
25MG
Marketing Status: Prescription
50MG
Marketing Status: Prescription
100MG
Marketing Status: Prescription
25MG
Marketing Status: Prescription
Active Ingredient: NITROFURANTOIN, MACROCRYSTALLINE
Proprietary Name: NITROFURANTOIN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A201722
Product Number: 001
Approval Date: Feb 16, 2016
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
NITROFURANTOIN (NITROFURANTOIN, MACROCRYSTALLINE)
Proprietary Name: NITROFURANTOIN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A201722
Product Number: 001
Approval Date: Feb 16, 2016
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
50MG
Marketing Status: Prescription
Active Ingredient: NITROFURANTOIN, MACROCRYSTALLINE
Proprietary Name: NITROFURANTOIN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 50MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A201722
Product Number: 002
Approval Date: Feb 16, 2016
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
NITROFURANTOIN (NITROFURANTOIN, MACROCRYSTALLINE)
Proprietary Name: NITROFURANTOIN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 50MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A201722
Product Number: 002
Approval Date: Feb 16, 2016
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
100MG
Marketing Status: Prescription
Active Ingredient: NITROFURANTOIN, MACROCRYSTALLINE
Proprietary Name: NITROFURANTOIN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A201722
Product Number: 003
Approval Date: Feb 16, 2016
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES INC
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: NITROFURANTOIN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A201722
Product Number: 003
Approval Date: Feb 16, 2016
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES INC
Marketing Status: Prescription
Patent and Exclusivity Information